Brody MJ, Feng L, Grimes AC, Hacker TA, Olson TM, Kamp TJ, Balijepalli RC, Lee Y. LRRC10 is required to maintain cardiac function in response to pressure overload. Am J Physiol Heart Circ Physiol 310: H269 -H278, 2016. First published November 25, 2015 doi:10.1152/ajpheart.00717.2014.-We previously reported that the cardiomyocyte-specific leucine-rich repeat containing protein (LRRC)10 has critical functions in the mammalian heart. In the present study, we tested the role of LRRC10 in the response of the heart to biomechanical stress by performing transverse aortic constriction on Lrrc10-null (Lrrc10 Ϫ/Ϫ ) mice. Mild pressure overload induced severe cardiac dysfunction and ventricular dilation in Lrrc10 Ϫ/Ϫ mice compared with control mice. In addition to dilation and cardiomyopathy, Lrrc10 Ϫ/Ϫ mice showed a pronounced increase in heart weight with pressure overload stimulation and a more dramatic loss of cardiac ventricular performance, collectively suggesting that the absence of LRRC10 renders the heart more disease prone with greater hypertrophy and structural remodeling, although rates of cardiac fibrosis and myocyte dropout were not different from control mice. Lrrc10 Ϫ/Ϫ cardiomyocytes also exhibited reduced contractility in response to ␤-adrenergic stimulation, consistent with loss of cardiac ventricular performance after pressure overload. We have previously shown that LRRC10 interacts with actin in the heart. Here, we show that His 150 of LRRC10 was required for an interaction with actin, and this interaction was reduced after pressure overload, suggesting an integral role for LRRC10 in the response of the heart to mechanical stress. Importantly, these experiments demonstrated that LRRC10 is required to maintain cardiac performance in response to pressure overload and suggest that dysregulated expression or mutation of LRRC10 may greatly sensitize human patients to more severe cardiac disease in conditions such as chronic hypertension or aortic stenosis. CARDIOMYOCYTE HYPERTROPHY in response to extracellular stimuli, such as neurohumoral or growth factor stimulation of membrane-bound receptors (13, 23, 44), or in response to mechanical stretch or strain that is sensed by mechanosensory machinery embedded in the Z-disc cytoskeleton, and sarcolemma (25, 38, 49). At the whole organ level, the heart undergoes hypertrophy as an adaptive mechanism to maintain cardiac output and reduce ventricular wall stress (20, 23, 38) . While initially beneficial, prolonged cardiac hypertrophy becomes maladaptive and progresses to cardiac dilation, decompensation, heart failure, and/or sudden death (20, 23, 38) . Cardiac hypertrophy can be induced by a number of cardiovascular diseases, such as myocardial infarction or chronic hypertension (23, 37). Indeed, high blood pressure is a common precursor to heart disease, particularly in the United States, where chronic hypertension is widespread (18, 21, 42) . Despite increased awareness and treatment of hypertension, recent epidemiological studies have suggested that its prevalence continues to rise, affecting ϳ55-65 million adults in the United States alone (18, 21) . Therefore, understanding the factors that are required to maintain cardiac function in the setting of pressure overload is critical for developing efficacious therapeutic strategies to treat heart disease.
CARDIOMYOCYTE HYPERTROPHY in response to extracellular stimuli, such as neurohumoral or growth factor stimulation of membrane-bound receptors (13, 23, 44) , or in response to mechanical stretch or strain that is sensed by mechanosensory machinery embedded in the Z-disc cytoskeleton, and sarcolemma (25, 38, 49) . At the whole organ level, the heart undergoes hypertrophy as an adaptive mechanism to maintain cardiac output and reduce ventricular wall stress (20, 23, 38) . While initially beneficial, prolonged cardiac hypertrophy becomes maladaptive and progresses to cardiac dilation, decompensation, heart failure, and/or sudden death (20, 23, 38) . Cardiac hypertrophy can be induced by a number of cardiovascular diseases, such as myocardial infarction or chronic hypertension (23, 37) . Indeed, high blood pressure is a common precursor to heart disease, particularly in the United States, where chronic hypertension is widespread (18, 21, 42) . Despite increased awareness and treatment of hypertension, recent epidemiological studies have suggested that its prevalence continues to rise, affecting ϳ55-65 million adults in the United States alone (18, 21) . Therefore, understanding the factors that are required to maintain cardiac function in the setting of pressure overload is critical for developing efficacious therapeutic strategies to treat heart disease.
Cardiac remodeling can be characterized as concentric or eccentric. Concentric hypertrophy occurs in pressure overload, such as from chronic hypertension or aortic valve stenosis, or in inherited hypertrophic cardiomyopathy induced by mutations in genes encoding sarcomeric proteins (22, 37, 38, 46, 49) . Concentric hypertrophy results from the addition of sarcomeres in parallel within cardiomyocytes, resulting in greater myocyte cell surface area, disproportionate growth in cardiomyocyte width relative to length, and thickening of the ventricular wall (26, 52) . In contrast, eccentric cardiac hypertrophy is caused by serial addition of sarcomeres, resulting in a disproportionate increase in the length relative to the width of cardiomyocytes that causes ventricular dilation (26, 52) . Eccentric cardiac hypertrophy occurs in conditions of volume overload, such as valvular regurgitation or after myocardial infarction, and in inherited cardiomyopathies associated with a wide range of genes, including many cytoskeletal and Z-disc genes (8, 11, 19, 26, 29, 37, 50, 56) . Therefore, the heart hypertrophies in response to a variety of pathological stimuli; however, the nature and resulting geometry of cardiac remodeling are stimulus dependent.
Leucine-rich repeat containing protein (LRRC)10 is a cardiac-specific member of the LRRC superfamily, which have in common LRR motifs that function as protein interaction domains (31, 33) . LRRC10 has no other known functional domains other than its LRRs (28) , suggesting that it mediates its biological functions by interacting with other proteins. Lrrc10 is expressed exclusively in cardiomyocytes and is dramatically upregulated after birth, with robust expression maintained in the adult heart (7, 28) , implying important roles in the postnatal heart. LRRC10 interacts with actin and ␣-actinin in the heart (8) and localizes at the dyad region where the Z-disc comes into close juxtaposition to the T-tubule and sarcoplasmic reticulum (8, 28) . This places LRRC10 at a mechanosensitive signaling hub in cardiomyocytes (19) .
Lrrc10-null (Lrrc10
) mice exhibit perinatal defects in cardiac function and moderate dilated cardiomyopathy in adulthood (8) . We have also recently reported that the cardiomyocyte-specific expression of Lrrc10 is regulated by Nkx2.5, GATA4, and serum response factor (7). Importantly, heterozygous missense mutations in LRRC10 have been recently identified in human dilated cardiomyopathy patients (43) . This strongly supports our working model that LRRC10 is a dilated cardiomyopathy candidate gene in humans. However, the roles of LRRC10 in the context of pathological stimulation, such as pressure overload, remain unknown.
In the present study, we performed transverse aortic constriction (TAC) on Lrrc10 Ϫ/Ϫ mice to test the hypothesis that LRRC10 is important for the response of the heart to mechanical stress. Lrrc10 Ϫ/Ϫ mice exhibit severely deteriorated cardiac function after 4 week of mild pressure overload stimulation, whereas cardiac function in wild-type (WT) mice is preserved. Interestingly, Lrrc10 Ϫ/Ϫ hearts undergo a normal concentric growth response and show similar increases in apoptosis or fibrosis in response to TAC compared with control hearts. These data indicate that LRRC10 is uniquely required to maintain cardiac contractile performance but is not necessary for concentric cardiac remodeling in the setting of pressure overload. Additionally, we demonstrate that His 150 of LRRC10 mediates its interaction with actin in the heart and that the interaction of LRRC10 with actin is reduced after pressure overload, suggesting a potential mechanosensing function for LRRC10.
EXPERIMENTAL PROCEDURES

Animals. Lrrc10
Ϫ/Ϫ mice have been previously described (8, 39) .
Experiments used Lrrc10
Ϫ/Ϫ mice and littermate or age-matched WT control mice maintained on the same C57BL/6 genetic background (8, 39) . Mice were euthanized by cervical dislocation to harvest tissue for biochemical and histological analyses. All procedures were performed in accordance with the National Institutes of Health (NIH) Guide for the Care and Use of Laboratory Animals and University of Wisconsin Research Animal Resource Center policies and approved by the Institutional Animal Care and Use Committee of the University of Wisconsin (protocol no. M01461).
TAC and echocardiography. TAC was performed to induce pressure overload hypertrophy as previously described (6, 10) . Briefly, 3-mo-old mice were anesthetized by face mask administration of 3% isofluorane and then intubated and placed on a ventilator (Harvard Apparatus) with supplemental O 2 and 1.5% isoflurane using a tidal volume of 0.2 ml and a respiratory rate of 110 breaths/min. The chest cavity was entered in the second intercostal space at the upper sternal border through a small incision, and aortic constriction was performed by tying a 7-0 nylon suture ligature against a 27-gauge needle. The needle was then removed, and the pneumothorax was evacuated and extubated. Subcutaneous buprenorphine (0.8 mg/kg) was administered for pain relief, and mice were allowed to recover in a heated chamber with 100% O 2. Pressure gradients across the constriction were estimated from Doppler echocardiography using the modified Bernoulli equation. Animals were euthanized, and tissues harvested for analysis after 28 days of TAC.
Transthoracic echocardiography was performed on mice under 1% isofluorane gas anesthesia using a Visual Sonics 770 ultrasonograph with a 30-MHz transducer (RMV 707B, Visual Sonics, Toronto, ON, Canada) as previously (8, 22) . Two-dimensional guided M-mode images of the left ventricle (LV) were acquired at the tips of the papillary muscles. Doppler experiments at the level of the aortic constriction were also acquired. The LV mass-to-body weight ratio, LV internal diameter (LVID) at diastole, thickness of the posterior walls at diastole, and isovolumetric relaxation time were recorded. Parameters were measured over at least three consecutive cycles (8, 10, 58) .
Histology and immuohistochemistry. Hematoxylin and eosin staining was done as previously described (8). Masson's trichrome (Sigma) and TUNEL (Millipore) staining of cardiac sections prepared from paraffin-embedded hearts were performed to detect collagen deposition and apoptosis, respectively, according to the manufacturer's instructions. Cardiomyocyte cross-sectional area was measured in wheat germ agglutinin (conjugated to Oregon green 488, 10 g/ml, Invitrogen)-stained cardiac sections costained with phalloidin (conjugated to Alexa fluor 546, 165 nM, Invitrogen). Cross-sectional area was evaluated in at least 300 cardiomyocytes/animal from identical areas of the LV (8) . Fibrosis was quantified as previously described (12) using images taken from the LV free wall of trichrome-stained cardiac sections, and percent fibrosis was averaged from seven ϫ20 images per heart. Imaging of heart sections was done on a Zeiss Axiovert 200 microscope with Zeiss AxioCam. Morphometric quantitation was performed with NIH ImageJ software.
For cryosectioning, hearts isolated 4 wk after TAC or sham surgeries were transferred into 30% sucrose in PBS for 1 h and then placed in a 1:1 mixture of 30% sucrose in PBS and OCT compound for an additional hour. Hearts were then embedded in 100% OCT compound and frozen on dry ice before being sectioned at 10 m on a Leica CM3050S cryostat. For immunohistochemistry, sections were fixed in acetone for 15 min at Ϫ20°C and blocked in PBS with 0.1% Tween 20 (PBST), 5% normal goat serum, and 2 mg/ml BSA for 1 h. Sections were incubated with LRRC10 (NBP1-81704, Novus Biologicals) and ␣-sarcomeric actin (A-2172, Sigma), ␣-actinin (A-7811, Sigma), or ryanodine receptor (MA3-925, Thermo Pierce) primary antibodies at a 1:200 dilution for 1 h followed by the appropriate secondary Alexa fluor antibodies (Molecular Probes) in PBST for 90 min. Slides were mounted using Prolong Gold Antifade Reagent with 4',6-diamidino-2-phenylindole (Life Technologies). Images were acquired and processed using a fluorescent microscope (ECLIPSE 90i, Nikon), NIS-Elements software suite (Nikon), and Photoshop in Adobe Creative Suite.
Generation of LRRC10 mutants and glutathione-S-transferase pulldown assays. Repeat Conservation Mapping (24) was used to identify the residues in LRRC10 that are likely to be important for proteinprotein interactions. A model of the predicted structure of mouse LRRC10 was created with 3D Jigsaw (4) and visualized with First Glance in Jmol to map the location of putative functionally important amino acids within LRRC10. To produce the glutathione-S-transferase (GST)-LRRC10 fusion protein, mouse Lrrc10 was amplified by PCR and inserted in frame into the pGEX-2T vector containing NH2-terminal GST (GE Healthcare) (8) . Mutant GST-LRRC10 fusion proteins were generated using the QuikChange II XL Site-Directed Mutagenesis Kit (Agilent Technologies) to mutate the WT GST-LRRC10 sequence. All new constructs were subjected to diagnostic digestion and confirmed by DNA sequencing. The oligonucleotides used to generate point mutations in LRRC10 were as follows: LRRC10 Y104A forward 5=-GAAACAGCTCTGCATCCTCGC-CCTGG-3=; LRRC10 W127A forward 5=-GAACCTACGGAC-CCTGGCGCTCGAAT-3=; and LRRC10 H150A forward 5=-TCTC-CTTAAAACCCTGGCTGCCGGTTC-3=.
GST, GST-LRRC10, or mutant GST-LRRC10 proteins were expressed in Esherichia coli BL21 (DE3, Merck) and purified with glutathione agarose (Sigma) as previously described (8, 41) . Pulldown assays were performed with purified rabbit skeletal muscle ␣-actin (AKL95, Cytoskeleton) exactly as previously described (8) . For pulldown of heart extracts, adult WT mouse hearts were homogenized in extraction buffer [50 mM Tris·HCl (pH 7.4), 150 mM NaCl, 1% Triton X-100, 0.4% sodium deoxycholate, and protease inhibitors], and lysates were diluted in lysate incubation buffer [20 mM Tris·HCl (pH 8.0), 100 mM NaCl, 1 mM EDTA, and 1% Triton X-100] and incubated with GST, GST-LRRC10, or GST-LRRC10
H150A for 2 h. Proteins bound to beads were then washed in lysate incubation buffer, resolved by SDS-PAGE, and immunoblotted.
Quantitative real-time PCR, Western blot analysis, and immunoprecipitation. Quantitative real-time PCR was performed using FastStart SYBR Green Master (Roche) on a Bio-Rad iCycler as previously described (8) . Data were generated using the standard curve method and normalized to 18S rRNA expression levels. Primers were evaluated by melt curve analysis to ensure specific amplification of a single, desired amplicon. Primer sequences for 18S, atrial natriurtic factor (ANF; Nppa), and ␤-myosin heavy chain (␤-MHC; Myh7) have been previously published (8) .
Immunoblot analysis was performed using standard methods with primary antibodies for LRRC10 (28) and ␣-sarcomeric actin (Sigma) as previously described (8, 9) . For coimmunoprecipitation, cardiac lysates were made in extraction buffer as described for GST pulldown assays from mice 4 wk after sham or TAC surgery and diluted in lysate incubation buffer containing rabbit IgG (Santa Cruz Biotechnology) or anti-LRRC10 (1) coupled to protein G Dynabeads (Invitrogen) and incubated overnight at 4°C. Protein G beads were then washed three times with lysate incubation buffer, and immunoprecipitated proteins were eluted, resolved by SDS-PAGE, and immunoblotted as described above (9) .
Myocyte fractional shortening. Myocyte contractility was measured simultaneously in freshly isolated ventricular myocytes from WT and Lrrc10 Ϫ/Ϫ mice. Isolated cardiomyocytes were incubated with Tyrode solution (142 mM NaCl, 5.4 mM KCl, 1 mM MgCl 2, 1.8 mM CaCl 2, 5 mM glucose, 5 mM HEPES, and 0.33 mM Na2HPO4, pH 7.4 with NaOH) in a temperature-controlled chamber at 37°C. Myocyte length was measured using a video-based microscope camera system (IonOptix, Milton, MA). After cells had been allowed to settle down for 5 min, stable rod-shaped cardiomyocytes with clear striations were field stimulated for 5 min at 0.5 Hz using 2-ms pulses at twice of the threshold voltages applied to two remote platinum electrodes placed in the perfusing solution by myopacer (IonOptix). Only myocytes with a resting sarcomere length of Ͼ1.7 m that followed the field stimulation protocol 1:1 were used. Once the steady stimulation had been established, myocytes were stimulated at frequencies of 0.5, 1, and 2 Hz separately for at least 10 continuous contractions at each stimulation frequency. Isoproterenol (Iso; 10 nM) was then applied through the perfusion solution, and recording was repeated under a similar pacing stimulation. Myocyte length was calculated by performing fast Fourier transforms of the images, and the resulting plot of the calculated myocyte length was recorded. The indexes used to describe myocyte contractility were fractional shortening (FS), time to peak (in ms), and time to 50% relaxation. All indexes were analyzed offline using IonWizard (IonOptix) and were obtained by averaging 10 steady-state transients for each myocyte.
Statistical analyses. All results are expressed as means Ϯ SE except for those in Fig. 7 , where results are expressed as means Ϯ SD. All statistical analysis was performed by a Student's t-test unless otherwise stated. P values of Ͻ0.05 were considered statistically significant.
RESULTS
Lrrc10
Ϫ/Ϫ mice exhibit increased cardiac growth in response to pressure overload. To test the role of LRRC10 in the response of the heart to biomechanical stress, we performed TAC on mice to induce pressure overload hypertrophy. The cardiac structure and function of Lrrc10 Ϫ/Ϫ mice were evaluated after 28 days of pressure overload stimulation compared with WT control mice. Lrrc10 Ϫ/Ϫ mice underwent greater cardiac growth and ventricular dilation than WT mice after TAC as observed by histology (Fig. 1A) . The heart weight-tobody weight ratios indicated a modest increase in cardiac growth in Lrrc10 Ϫ/Ϫ mice at baseline (Fig. 1B) , as previously reported (8) . However, in response to TAC, Lrrc10 Ϫ/Ϫ mice underwent substantially more cardiac enlargement than WT mice (54% increase in the heart weight-to-body weight ratio compared with 34% in WT mice; Fig. 1B ). Control and Lrrc10 Ϫ/Ϫ mice experienced an equivalent, relatively mild (see DISCUSSION) pressure overload stimulus from the TAC procedure (Fig. 1C) , indicating that differences in cardiac growth or function after TAC are due to the absence of LRRC10. Expression of the hypertrophy marker genes Nppa (ANF) and Myh7 (␤-MHC) were analyzed by quantitative PCR. As previously reported (8) , adult Lrrc10 Ϫ/Ϫ hearts exhibited a mild induction of ANF and robust increase in ␤-MHC expression without hypertrophic stimulation (Fig. 1, D and E) . In response to pressure overload, Lrrc10 Ϫ/Ϫ mice induced ANF expression to a similar extent as WT mice (Fig. 1D) . ␤-MHC expression was elevated in Lrrc10 Ϫ/Ϫ hearts compared with WT hearts at baseline and after TAC (Fig. 1E) .
Deletion of Lrrc10 greatly exacerbates cardiac dysfunction in response to pressure overload. Next, we tested the hypothesis that LRRC10 is important for cardiac function in response to pressure overload by performing echocardiography on control and Lrrc10 Ϫ/Ϫ mice after TAC or sham surgery.
Ϫ/Ϫ mice underwent significant increases in LVID during systole ( Fig. 2A) and diastole (Fig. 2B ) in response to TAC, whereas LV dimensions were not altered in WT mice (Fig. 2,  A and B) . These data indicate that pressure overload greatly exacerbates ventricular dilation in Lrrc10 Ϫ/Ϫ mice compared with WT mice. At baseline, Lrrc10 Ϫ/Ϫ mice had moderate dilated cardiomyopathy with increased LVID at diastole and systole and decreased FS and ejection fraction compared with WT mice, as we have previously reported (8) . However, after TAC, cardiac contractility was severely compromised in Lrrc10 Ϫ/Ϫ mice, with drastically reduced FS ( Fig. 2C and Table 1 ) and ejection fraction (Fig. 2D and Table 1 ) compared with sham-operated mice, whereas these parameters were not significantly reduced in WT mice in response to TAC (Fig. 2,  C and D) .
Comparison of echocardiographic functional parameters before and after 28 days of TAC revealed that Lrrc10 Ϫ/Ϫ hearts underwent much greater reductions in cardiac functional performance due to pressure overload (Fig. 2, E and F Ϫ/Ϫ hearts and suggesting poor cardiac performance and functional decompensation after pressure overload. Lrrc10 Ϫ/Ϫ mice had significantly elevated heart rates after TAC (Table 1) , resulting in a maintenance of cardiac output (data not shown) despite a marked reduction in cardiac function (Fig. 2, C-F) . Representative M-mode images showed modest dilated cardiomyopathy in sham-operated Lrrc10 Ϫ/Ϫ mice versus WT mice but greatly exacerbated cardiomyopathy and LV dilation in Lrrc10 Ϫ/Ϫ mice after TAC (Fig. 2G) . In contrast, cardiac structure and function were largely preserved in WT mice after TAC ( Fig.  2G and Table 1 ).
Closer examination of hematoxylin and eosin-stained cardiac sections revealed that Lrrc10 Ϫ/Ϫ hearts exhibited overtly normal cardiac morphology in response to pressure overload without histological abnormalities such as myocyte disarray or alterations in myocyte size between WT and Lrrc10 Ϫ/Ϫ hearts (Fig. 3A, top) . No differences in fibrosis were detected between WT and Lrrc10 Ϫ/Ϫ hearts after TAC by Masson's trichrome staining (Fig. 3A, bottom, and B) . Measurements of myocyte cross-sectional area from wheat germ agglutinin-stained cardiac sections demonstrated similar increases in WT and Lrrc10 Ϫ/Ϫ mice in response to TAC (Fig. 3, C and D) . This suggests that LRRC10 is dispensable for appropriate concentric LV hypertrophy in response to pressure overload. To further evaluate the nature of cardiac remodeling after pressure overload, the relative wall thickness or ratio of LV wall and septal thickness to LV chamber radius (H/R ratio) was calculated from echocardiography data. The reduced H/R ratios in Lrrc10 Ϫ/Ϫ versus WT mice after sham surgery indicated eccentric cardiac growth and dilation at baseline (Fig. 3E) , as previously reported (8) . Lrrc10 Ϫ/Ϫ mice exhibited a robust concentric hypertrophy response to pressure overload stimulation, as evidenced by the significant increase in the H/R ratio after TAC (Fig. 3E) , consistent with myofiber area measurements (Fig. 3D) .
Despite severely impaired cardiac function (Fig. 2) , Lrrc10 Ϫ/Ϫ hearts underwent a similar degree of cardiac fibrosis after pressure overload compared with WT hearts, as detected by Masson's trichrome staining (Fig. 3A, bottom) . Moreover, no difference in the induction of the fibrotic marker gene connective tissue growth factor (Ctgf) was detected between
WT and Lrrc10
Ϫ/Ϫ hearts with or without TAC surgery by quantitative PCR (data not shown), consistent with histological analyses (Fig. 3A) . There was no difference in cardiomyocyte apoptosis in Lrrc10 Ϫ/Ϫ hearts compared with WT control hearts 28 days after TAC or sham surgery (Fig. 4, A and B) , indicating that apoptosis does not exacerbate pressure overload-induced cardiomyopathy in Lrrc10 Ϫ/Ϫ mice. Therefore, although cardiac functional performance is drastically reduced in Lrrc10 Ϫ/Ϫ mice after pressure overload, the extent of cardiac fibrosis and apoptosis are unchanged compared with WT mice.
His150 of LRRC10 mediates binding to actin. Some actinbinding proteins are critical for the response of the heart to biomechanical stress (5, 17, 34, 55) , suggesting that localization to the Z-disc or actin cytoskeleton within the cardiomyocyte provides an optimal environment for sensing or transduc- Values are means Ϯ SE. Shown is the evaluation of cardiac structural and functional parameters by echocardiography in leucine-rich repeat containing 10-deficient (Lrrc10 Ϫ/Ϫ ) and control wild-type (WT) mice at various ages. LVIDd and LVIDs, left ventricular (LV) inner diameter at diastole and systole, respectively; LVPWd and LVPWs, LV posterior wall at diastole and systole, respectively; LVAWd and LVAWs, LV anterior wall at diastole and systole, respectively; EF, ejection fraction; FS, fractional shortening. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 compared with WT mice subjected to the same treatment; #P Ͻ 0.05 and ##P Ͻ 0.01 compared with sham-operated mice of the same genotype. Ϫ/Ϫ hearts in response to TAC, indicating that Lrrc10 Ϫ/Ϫ mice undergo normal concentric hypertrophy in response to pressure overload. Values are averages of n ϭ 3-4 animals. At least 300 myocytes were evaluated per heart. Scale bars ϭ 10 m. E: ratios of LV wall and septal thickness to LV chamber radius (H/R ratios) or relative wall thicknesses were calculated from echocardiography data. The decreased H/R ratios in sham-operated Lrrc10 Ϫ/Ϫ hearts indicate dilation or eccentric cardiac growth, and the increased H/R ratios after TAC indicate a normal concentric growth in response to TAC. n ϭ 7-11. *P Ͻ 0.05; **P Ͻ 0.01. ing signals in response to mechanical stretch or strain. We have shown that LRRC10 interacts with ␣-actin in the heart and all actin isoforms in vitro (8) , suggesting that LRRC10 serves as a pan-actin-binding protein. LRRCs physically interact with other proteins via hydrophobic residues on the interior concave face of the solenoid-shaped structure imparted by the LRR domains (31) (32) (33) . To probe further into mechanisms mediating interactions of LRRC10 with actin, we used Repeat Conservation Mapping, a computational method to predict functional sites in LRR domains (24) , to predict protein-protein interaction sites in LRRC10. Residues Tyr 104 , Trp 127 , and His 150 were identified as putative functional sites in LRRC10, which mapped to the interior concave face of the predicted protein structure of LRRC10 (Fig. 5A) . To determine if these amino acids are critical for the interaction of LRRC10 with actin, Tyr 104 , Trp
127
, or His 150 were mutated to alanine, and in vitro pulldown assays were performed with GST or a GST-LRRC10 fusion protein and purified ␣-actin (Fig. 5B) . As expected, GST fusion protein containing WT LRRC10 interacted with actin, whereas GST alone did not. Mutation of Tyr 104 or Trp 127 did not affect the interaction of LRRC10 with actin. In contrast, mutation of His 150 of LRRC10 abrogated its interaction with actin (Fig. 5B) , indicating that His 150 of LRRC10 is essential for actin binding. To test if His 150 is important for the interaction of LRRC10 with actin in the heart, mouse heart extracts were incubated and pulled down with GST, GST-LRRC10, or GST-LRRC10 H150A and then immunoblotted for ␣-actin (Fig.  5C ). WT LRRC10 interacted with ␣-actin in the heart, as previously reported (8), but mutation of His 150 abolished the interaction of LRRC10 with actin (Fig. 5C ), indicating that His 150 of LRRC10 is a functional actin-binding site. Predictive modeling of the structures of WT LRRC and mutant LRRC10
H150A illustrated a similar protein conformation (Fig.  5D ), suggesting mutation of this histidine to alanine did not change the overall conformation of LRRC10 but specifically altered the actin-binding motif within LRRC10.
We next determined if the interaction of LRRC10 with actin in the heart is altered in response to biomechanical stress. We performed immunoprecipitation with an LRRC10 antibody on cardiac lysates from sham or TAC-operated mice and immunoblotted for actin. The results demonstrated a reduced interaction of LRRC10 with actin in TAC hearts (Fig. 6A) , indicating that binding of LRRC10 to actin is reduced during pressure overload and that the association of LRRC10 with actin thin filaments is dynamically regulated in response to mechanical stress. To determine if LRRC10 undergoes a substantial change in subcellular localization after pressure overload, immunohistochemistry was performed on cardiac sections from sham or TAC mice. Intracellular localization of LRRC10 appeared normal in TAC hearts compared with , which were predicted to be functional sites with Repeat Conservation Mapping. B, top: glutathione-S-transferase (GST) pulldown assays indicated that residue His 150 of LRRC10 is critical for its physical interaction with actin. Purified ␣-actin was incubated with GST or GST fusion proteins containing LRRC10 or a mutant LRRC10 containing Tyr 104 , Trp 127 , or His 150 mutated to alanine followed by immunoblot analysis for ␣-actin. Bottom, Coomassie-stained gels demonstrating equal loading conditions. C: His 150 of LRRC10 is required for the interaction with actin in the heart. Mouse heart extract was incubated with GST, GST-LRRC10, or GST-LRRC10 H150A and then immunoblotted for ␣-actin, indicating that GST-LRRC10 but not GST or the GST-LRRC10
H150A mutant interacts with actin in cardiac lysates. D: models of the predicted structures of WT LRRC10 and mouse LRRC10
H150A .
sham-operated hearts (Fig. 6B) . Despite the reduced interaction of LRRC10 and ␣-actin, LRRC10 properly colocalized in a striated pattern with ␣-actin (Fig. 6B) as well as the Z-disc protein ␣-actinin and the ryanodine receptor, a sarcoplasmic reticulum protein, in both control and pressureoverloaded hearts (data not shown). These data indicate that LRRC10 remains at or near the dyad region under pressure overload, maintaining its close proximity to the Z-disc, sarcoplasmic reticulum, and T-tubule. Myocyte contractility. To determine if the absence of LRRC10 alters cardiomyocyte contractile function, single cell contractility was evaluated in myocytes isolated from WT and Lrrc10 Ϫ/Ϫ hearts. The impact of loss of LRRC10 on myocyte contractile function was determined by measuring myocyte shortening (FS) under field stimulation. Baseline FS was not significantly different between myocytes from WT and Lrrc10 Ϫ/Ϫ mice at all stimulation frequencies (0.5, 1, and 2 Hz; Fig. 7, A and B) . However, after perfusion with 10 nM Iso, FS was significantly increased at all stimulation frequencies in WT myocytes, whereas FS in ventricular myocytes from Lrrc10 Ϫ/Ϫ hearts did not increase in response to Iso (Fig. 7, A and B) , demonstrating that Lrrc10 Ϫ/Ϫ myocytes exhibit a defective contractile response to ␤-adrenergic stimulation. Furthermore, we analyzed the ratio of FS after and before Iso treatment and found that this ratio was significantly reduced in Lrrc10 Ϫ/Ϫ myocytes compared with WT myocytes at 1 and 2 Hz (Fig.  7C) , further highlighting the impaired contractile response of Lrrc10 Ϫ/Ϫ myocytes in response to Iso. The time to peak contraction and time of 50% relaxation were not altered in Lrrc10 Ϫ/Ϫ and WT myocytes under basal conditions and with Iso perfusion (Fig. 7, D and E) .
DISCUSSION
Pressure overload occurs in response to cardiovascular diseases, including hypertension and LV outflow tract obstruction, and results in concentric cardiac hypertrophy that, when prolonged, becomes maladaptive and can progress to congestive heart failure (14, 27, 36, 37, 42) . Pressure overload activates mechanosensitive signals that increase myocardial mass via the addition of sarcomeres in parallel, resulting in radial growth of cardiomyocytes and increased LV wall thickness (26, 27, 37, 49) . Here, we tested the hypothesis that LRRC10 is important for the response of the heart to mechanical stress and pressure overload hypertrophy.
LRRC10 is a cardiomyocyte-specific factor required for proper cardiac function (1, 7, 8, 28) , and mutations in the LRRC10 gene have been recently linked to human dilated cardiomyopathy (43) . We demonstrated that Lrrc10 Ϫ/Ϫ mice exhibit severe cardiac dysfunction in response to TAC and that Lrrc10 Ϫ/Ϫ myocytes have reduced single cell contractility in response to adrenergic stimulation, indicating that LRRC10 is indispensable for the response of the mammalian heart to biomechanical stress. We have previously shown that LRRC10 interacts with actin and ␣-actinin (8), positioning it in an ideal location to sense or transduce signals in response to biomechanical stress. Embryonic hearts of Lrrc10 Ϫ/Ϫ mice upregulate a number of cytoskeletal genes critical for the response of the heart to mechanical stress (3, 8, 35, 47) , suggesting that the absence of LRRC10 may render the heart sensitive to stretch or strain. Here, we identified His 150 of LRRC10 as necessary for its interaction with actin and showed that this interaction is reduced after pressure overload. Mechanistically, how the interaction of LRRC10 with actin is reduced after TAC is unclear. However, the maintenance of a similar immunolocalization pattern that colocalizes with ␣-actin, ␣-actinin, and the sarcoplasmic reticulum indicates that LRRC10 remains within the dyad region in close proximity to actin. It is possible that posttranslational modifications or biomechanical signals in response to pressure overload result in the displacement of LRRC10 from actin thin filaments and/or association with other interacting factors or protein complexes at the Z-disc, costamere, sarcoplasmic reticulum, or T-tubule. Indeed, the close proximity of structures within the dyad region (45) makes it so that localization of LRRC10 at the Z-disc, T-tubule, or dyadic cleft is indistinguishable by immunohistochemistry. His 150 of LRRC10 is located on its interior concave face (Fig.  5A) . LRRCs commonly bind other interacting factors on this interior face of the ␣/␤-horseshoe fold imparted by LRRs (31, 32) , so posttranslational modifications and/or binding of other factors to LRRC10 near His 150 may be critical for its regulation. Future studies will investigate molecular defects in the LRRC10 His150Ala mutant as well as LRRC10 mutations recently identified in human dilated cardiomyopathy (43) .
Nonetheless, LRRC10 may serve as a cardiomyocyte-specific scaffolding protein to tether important structural or signaling molecules to mediate appropriate responses to mechanical stress. Z-disc proteins such as muscle LIM protein (2, 29) , Cypher (56, 57) , and telethonin (29, 30) are thought to compose a mechanosensory signalosome that allows the cardiomyocyte to internally sense and respond to mechanical stretch or strain. Moreover, LRRC39, a striated muscle-specific LRRC, Fig. 6 . Reduced interaction of LRRC10 with actin after pressure overload. A: heart extracts from TAC-or sham-operated mice were immunoprecipitated with an LRRC10 antibody and immunoblotted for ␣-actin, revealing a reduced association of LRRC10 and ␣-actin after pressure overload. IP, immunoprecipitation. *IgG light chain. B: immunohistochemistry for LRRC10 (green) and ␣-actin (red) was performed on cardiac sections of mice subjected to sham or TAC surgery, indicating normal colocalization of LRRC10 with ␣-actin near the Z-disc after pressure overload. 4=,6-Diamidino-2-phenylindole was used as a nuclear stain in the overlays (blue). Scale bar ϭ 10 m.
acts as a mechanosensor at the cardiomyocyte M-line by regulating serum response factor-dependent transcription (51) .
Importantly, Lrrc10 Ϫ/Ϫ mice develop severe dilated cardiomyopathy in response to 4 wk of mild pressure overload stimulation. In our hands, performance of TAC to surgically induce pressure overload resulted in a pressure gradient across the aortic constriction of Ͻ50 mmHg, which caused concentric hypertrophy with preserved cardiac function in control mice that did not progress to decompensation or present clinical signs of heart failure. This is a relatively mild stimulus compared with other TAC models that achieve a greater aortic pressure gradient and induce a robust hypertrophy response and decompensation of ventricular performance in control mice within 4 wk of pressure overload stimulation (15, 40, 48) . Therefore, our model of mild pressure overload serves as a good pathophysiological model of chronic hypertension, a condition that occurs in nearly one-third of Americans (18, 21) . Lrrc10 Ϫ/Ϫ mice exhibit severe cardiomyopathy and decompensated ventricular performance in response to mild pressure overload stimulation, yet are still capable of undergoing appropriate concentric cardiac hypertrophy. This suggests that LRRC10 is uniquely required to maintain functional performance but is not necessary for concentric cardiomyocyte growth in response to pressure overload. Lrrc10 Ϫ/Ϫ hearts become very dilated after TAC, indicative of eccentric growth, but also undergo pressure overload-induced concentric LV remodeling, with increased myocyte cross-sectional area and increased H/R ratios. Therefore, Lrrc10 Ϫ/Ϫ hearts likely undergo a combination of eccentric and concentric remodeling in response to TAC. We have previously reported that unstimulated adult Lrrc10 Ϫ/Ϫ cardiomyocytes are longer than WT cardiomyocytes (8), suggesting eccentric growth by the addition of sarcomeres in series, consistent with ventricular dilation. Thus, pressure overload worsens cardiac function in the absence of LRRC10, which may further increase neuroendocrine drive, providing a positive feedback loop that further enhances cardiac growth and exacerbates cardiac dysfunction.
The fact that Lrrc10 Ϫ/Ϫ mice exhibit greatly diminished cardiac function but a normal concentric hypertrophy response to TAC suggests that cardiac contractility is specifically compromised in the absence of LRRC10. Here, we demonstrated that Lrrc10 Ϫ/Ϫ mice display reduced cardiac function after pressure overload, whereas isolated Lrrc10 Ϫ/Ϫ myocytes exhibit normal contractility at baseline but a defective contractile response to ␤-adrenergic stimulation. Thus, LRRC10 is required for baseline cardiomyocyte contractile function in the loaded intact heart; however, in unloaded isolated myocytes, LRRC10 is not necessary for normal myofilament contraction. These data are in agreement with a potential role for LRRC10 as a mechanosensor in that only in the intact heart, where myocytes can sense preload and mechanical stretch, does the absence of LRRC10 manifest in reduced baseline contractile performance. We have shown that LRRC10 is not required for normal kinetics of myofilament contraction or for myofilament Ca 2ϩ sensitivity in skinned trabeculae (8) , indicating that LRRC10 does not directly regulate cardiomyocyte contraction at the level of the myofilament but rather may play fundamental roles in upstream signals required for proper excitationcontraction coupling. Unloaded isolated Lrrc10 Ϫ/Ϫ myocytes are unable to mount an appropriate contractile response to ␤-adrenergic stimulation, which is consistent with cardiomyopathy in Lrrc10 Ϫ/Ϫ mice but could alternatively be due to some direct role for LRRC10 in coupling ␤-adrenergic simulation and excitation-contraction coupling. Indeed, in other tissues, LRRCs have been shown to regulate ion channel function (16, 53, 54) . Therefore, we speculate that LRRC10 may play critical roles in cardiomyocyte electrophysiology and/or Ca 2ϩ handling, which is essential for regulating normal excitation-contraction coupling. These experiments do not identify the precise mechanism whereby Lrrc10 Ϫ/Ϫ mice exhibit reduced contractile function and increased susceptibility to cardiomyopathy but provide insights into the role of LRRC10 in human cardiac disease and pave the way for future studies investigating molecular mechanisms underlying cardiomyopathy when LRRC10 is absent or mutated. Lrrc10 Ϫ/Ϫ hearts do not exhibit increases in cardiac apoptosis or fibrosis compared with WT hearts in response to TAC, indicating that cardiomyocyte apoptotic cell death and fibrosis do not contribute to the advanced cardiomyopathy observed in Lrrc10 Ϫ/Ϫ mice after mild pressure overload, supporting a specific defect in cardiac functional performance. It is possible that systolic dysfunction in the embryonic Lrrc10 Ϫ/Ϫ heart sensitizes the adult Lrrc10 Ϫ/Ϫ heart to severe cardiac dysfunction after pressure overload. However, defects in cardiac functional performance in Lrrc10 Ϫ/Ϫ mice after TAC are far greater than the additive effects of basal dilated cardiomyopathy observed in unstimulated adult Lrrc10 Ϫ/Ϫ mice (8) combined with the cardiac phenotype of TAC-operated control mice, suggesting an inability of LRRC10-deficient hearts to cope with pressure overload. Therefore, Lrrc10 Ϫ/Ϫ mice represent a unique model of hypersensitivity to biomechanical stress that exhibit hypertensive cardiomyopathy after pressure overload without increased fibrotic remodeling or cardiomyocyte cell death. Our data suggest that human mutations in LRRC10 may increase susceptibility to more severe heart disease or heart failure in the setting of pressure overload, such as in patients with high blood pressure or aortic stenosis.
